Biomarkers PCA3 and TMPRSS2-ERG: better together

被引：0
|
作者：
机构：
来源：
Nature Reviews Urology | 2014年 / 11卷 / 3期
关键词：
D O I：
10.1038/nrurol.2014.38
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 129
相关论文
共 50 条
  • [21] PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
    Warli, Syah Mirsya
    Warli, Muhammad Haritsyah
    Prapiska, Fauriski Febrian
    RESEARCH AND REPORTS IN UROLOGY, 2023, 15 : 149 - 155
  • [22] Clinical performance of PCA3 and TMPRSS2:ERG urinary biomarkers for African American men undergoing prostate biopsy.
    Feibus, Allison H.
    Sartor, Oliver
    Thomas, Raju
    Maddox, Michael M.
    Lee, Benjamin
    Levy, Justin
    Stewart, Carrie A.
    Wang, Julie
    Moparty, Krishnarao
    Silberstein, Jonathan L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [23] Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy
    Feibus, Allison H.
    Sartor, Oliver
    Moparty, Krishnarao
    Chagin, Kevin
    Kattan, Michael W.
    Ledet, Elisa
    Levy, Justin
    Lee, Benjamin
    Thomas, Raju
    Silberstein, Jonathan L.
    JOURNAL OF UROLOGY, 2016, 196 (04): : 1053 - 1059
  • [24] PCA3 AND TMPRSS:ERG ASSESSMENT IN SEMEN: RESULTS OF A PHASE I STUDY.
    Punjani, Nahid
    Hayden, Russell P.
    Cai, Peter Y.
    Wei, John T.
    Siddiqui, Javed
    Dudley, Vanessa L.
    Feliciano, Miriam
    Goldstein, Marc
    FERTILITY AND STERILITY, 2020, 114 (03) : E389 - E389
  • [25] Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
    Tomlins, Scott A.
    Day, John R.
    Lonigro, Robert J.
    Hovelson, Daniel H.
    Siddiqui, Javed
    Kunju, L. Priya
    Dunn, Rodney L.
    Meyer, Sarah
    Hodge, Petrea
    Groskopf, Jack
    Wei, John T.
    Chinnaiyan, Arul M.
    EUROPEAN UROLOGY, 2016, 70 (01) : 45 - 53
  • [26] Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
    Newcomb, Lisa F.
    Zheng, Yingye
    Faino, Anna, V
    Bianchi-Frias, Daniella
    Cooperberg, Matthew R.
    Brown, Marshall D.
    Brooks, James D.
    Dash, Atreya
    Fabrizio, Michael D.
    Gleave, Martin E.
    Liss, Michael
    Morgan, Todd M.
    Thompson, Ian M.
    Wagner, Andrew A.
    Carroll, Peter R.
    Nelson, Peter S.
    Lin, Daniel W.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (03) : 438 - 445
  • [27] Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy COMMENTS
    Ritch, Chad R.
    JOURNAL OF UROLOGY, 2016, 196 (04): : 1059 - 1060
  • [28] Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
    Lisa F. Newcomb
    Yingye Zheng
    Anna V. Faino
    Daniella Bianchi-Frias
    Matthew R. Cooperberg
    Marshall D. Brown
    James D. Brooks
    Atreya Dash
    Michael D. Fabrizio
    Martin E. Gleave
    Michael Liss
    Todd M. Morgan
    Ian M. Thompson
    Andrew A. Wagner
    Peter R. Carroll
    Peter S. Nelson
    Daniel W. Lin
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 438 - 445
  • [29] RATIONAL BASIS FOR THE COMBINATION OF PCA3 AND TMPRSS2: ERG GENE FUSION IN PROSTATE CANCER DIAGNOSIS
    Robert, Gregoire
    Jannink, Sander
    Aalders, Tilly
    Mulders, Peter
    Schalken, Jack
    JOURNAL OF UROLOGY, 2011, 185 (04): : E648 - E648
  • [30] Urine PCA3 and TMPRSS2: ERG Using Cancer-specific Markers to Detect Cancer
    Tomlins, Scott A.
    EUROPEAN UROLOGY, 2014, 65 (03) : 543 - 545
12345